Virtual Reality for Medial Epicondyle Apophysitis

July 17, 2026 updated by: Nehad Ahmed Youness Abo-zaid, South Valley University

The Efficacy of Virtual Reality Training on Medial Epicondyle Apophysitis in Adolescent Athletes

Traction apophysitis of the medial epicondyle (MEC) is a common elbow injury in adolescent baseball players. The underlying pathology of the lesions associated with apophysitis seems to be due to repetitive traction stress via the medial ulnar collateral ligament (MUCL) to the skeletally immature MEC, as seen in young baseball players. Various types of morphological changes are observed at the MEC in baseball players, and fragmentation and hypertrophy have been commonly reported.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Phases of rehabilitation for Medial Epicondyle Apophysitis Phase I treatment involves resting and protecting the elbow to permit healing, to prevent further injury, and to control pain and swelling. Phase II treatment begins once pain and swelling have subsided to the point where the athlete can comfortably bear weight and walk from place to place. Virtual reality (VR) is a simulated experience that can be similar to or completely different from the real world. Applications of virtual reality can include entertainment (i.e. video games) and educational purposes (i.e. medical or military training). Other, distinct types of VR style technology include augmented reality and mixed reality.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Ola A KamalLecturer, Lecturer
  • Phone Number: 01118458838

Study Locations

  • Egypt
      • Asyut, Egypt
        • Nehad A Abo-zaid

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Cases diagnosed with medial epicondyle apophysitis.
  • Cases participated in this study will from both sexes.
  • Cases receiving standard treatment protocol.
  • Cases with a disease duration of more than four months.

Exclusion Criteria:

  • Cases with resent fractures in affected upper limb.
  • Cases diagnosis of any neurological disease or musculoskeletal disease affecting upper extremity functional ability.
  • Uncooperative cases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: The Control Group
Group (A)
Other: The Control Group
All adolescents will receive 60 min. of the selected physical therapy program including strengthening the muscles of upper limb, stretching for elbow flexors and forearms pronators
Other Names:
  • Group (A)
Experimental: The Study Group
Group (B)
Other: The Study Group
all adolescents will receive selected physical therapy program for 30 min. containing strengthening the muscles of upper limb, stretching for elbow flexors and forearms pronators plus 30 of virtual reality training
Other Names:
  • Group (B)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale
Time Frame: at day 0
pain assessment tool, the scale ranged from 0-10 (at which 0 indicate no pain and 10 indicate sever pain)
at day 0
Visual Analogue Scale
Time Frame: at day 90
pain assessment scale, the scale ranged from 0-10 (at which 0 indicate no pain and 10 indicate sever pain)
at day 90

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of Motion
Time Frame: at day 0
Elbow Flexion angle degree
at day 0
Range of Motion
Time Frame: at day 90
Elbow Flexion angle degree
at day 90
Range of Motion
Time Frame: at day 0
Elbow Extension angle degree
at day 0
Range of Motion
Time Frame: at day 90
Elbow Extension angle degree
at day 90

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

South Valley University

Investigators

  • Principal Investigator: Nehad A Abo-zaid, Assistant Professor, South Valley University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 20, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

October 20, 2026

Study Registration Dates

First Submitted

July 2, 2026

First Submitted That Met QC Criteria

July 17, 2026

First Posted (Actual)

July 20, 2026

Study Record Updates

Last Update Posted (Actual)

July 20, 2026

Last Update Submitted That Met QC Criteria

July 17, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/006533

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent Athelets

Clinical Trials on The Control Group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe